PL3171885T3 - Hydrolizat peptydowy ze ślimaków, frakcje peptydów, sposób wytwarzania, zastosowanie i kompozycje do hamowania enzymu konwertującego angiotensynę - Google Patents

Hydrolizat peptydowy ze ślimaków, frakcje peptydów, sposób wytwarzania, zastosowanie i kompozycje do hamowania enzymu konwertującego angiotensynę

Info

Publication number
PL3171885T3
PL3171885T3 PL15741979T PL15741979T PL3171885T3 PL 3171885 T3 PL3171885 T3 PL 3171885T3 PL 15741979 T PL15741979 T PL 15741979T PL 15741979 T PL15741979 T PL 15741979T PL 3171885 T3 PL3171885 T3 PL 3171885T3
Authority
PL
Poland
Prior art keywords
peptide
snails
inhibiting
compositions
production method
Prior art date
Application number
PL15741979T
Other languages
English (en)
Inventor
Pascal Drevet
Original Assignee
Pascal Drevet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pascal Drevet filed Critical Pascal Drevet
Publication of PL3171885T3 publication Critical patent/PL3171885T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL15741979T 2014-07-21 2015-07-21 Hydrolizat peptydowy ze ślimaków, frakcje peptydów, sposób wytwarzania, zastosowanie i kompozycje do hamowania enzymu konwertującego angiotensynę PL3171885T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1457023A FR3023717B1 (fr) 2014-07-21 2014-07-21 Hydrolysat peptidique d'escargots, fractions peptidiques, procede de fabrication, utilisation et compositions pour inhiber l'enzyme de conversion de l'angiotensine
PCT/EP2015/066652 WO2016012453A1 (fr) 2014-07-21 2015-07-21 Hydrolysat peptidique d'escargots, fractions peptidiques, procédé de fabrication, utilisation et compositions pour inhiber l'enzyme de conversion de l'angiotensine
EP15741979.7A EP3171885B1 (fr) 2014-07-21 2015-07-21 Hydrolysat peptidique d'escargots, fractions peptidiques, procédé de fabrication, utilisation et compositions pour inhiber l'enzyme de conversion de l'angiotensine

Publications (1)

Publication Number Publication Date
PL3171885T3 true PL3171885T3 (pl) 2019-10-31

Family

ID=52358840

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15741979T PL3171885T3 (pl) 2014-07-21 2015-07-21 Hydrolizat peptydowy ze ślimaków, frakcje peptydów, sposób wytwarzania, zastosowanie i kompozycje do hamowania enzymu konwertującego angiotensynę

Country Status (7)

Country Link
EP (1) EP3171885B1 (pl)
ES (1) ES2728096T3 (pl)
FR (1) FR3023717B1 (pl)
LT (1) LT3171885T (pl)
PL (1) PL3171885T3 (pl)
SI (1) SI3171885T1 (pl)
WO (1) WO2016012453A1 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210262A1 (de) * 1972-03-03 1973-09-06 Bayer Ag Polyvalente proteaseninhibitorpraeparate aus helix pomatia

Also Published As

Publication number Publication date
WO2016012453A1 (fr) 2016-01-28
ES2728096T3 (es) 2019-10-22
LT3171885T (lt) 2019-06-25
FR3023717B1 (fr) 2017-12-08
EP3171885A1 (fr) 2017-05-31
SI3171885T1 (sl) 2019-08-30
FR3023717A1 (fr) 2016-01-22
EP3171885B1 (fr) 2019-02-27

Similar Documents

Publication Publication Date Title
EP3266792A4 (en) Peptide synthesis method
EP3186277A4 (en) Antibodies, compositions, and uses
EP3102670A4 (en) Systems, methods, and compositions relating to combiomics
EP3122346A4 (en) Trka kinase inhibitors, compositions and methods thereof
EP3182985A4 (en) Fibroin-derived protein composition
EP3122344A4 (en) TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
EP3140305A4 (en) Novel compositions, uses and methods for making them
EP3119204A4 (en) Compositions and methods for improving tomato production
EP3157685A4 (en) Methods for generating stabilized lyophilized materials
EP3096757A4 (en) Apilimod compositions and methods for using same
EP3166892A4 (en) Scale-inhibition compositions and methods of making and using the same
EP3325608A4 (en) METHODS AND MICROORGANISMS FOR PRODUCING 1,3-BUTANEDIOL
EP3197469A4 (en) Stevia composition, production method and uses
EP3257201A4 (en) Improvements relating to messaging gateways
EP3207093A4 (en) Resin compositions and methods for making and using same
EP3126465A4 (en) Sealing composition and method of producing the same
EP3148564A4 (en) Methods and compositions for immunomodulation
IL252448B (en) A tripeptide compound, a method for its preparation and its application
EP3113774A4 (en) Compositions of grapiprant and methods for using the same
EP3110435A4 (en) Methods and compositions for the delayed treatment of stroke
EP3134465A4 (en) Improved coating compositions and processes for making the same
EP3135763A4 (en) Method for improving protein expression, and composition for protein expression
EP3122369A4 (en) Cyclic prosaposin peptides and uses thereof
EP3222629A4 (en) Novel peptide compound, production method therefor, and use thereof
EP3113781A4 (en) Sialylated glycoprotein compositions and uses thereof